Intellia Therapeutics Inc (NASDAQ:NTLA)
| 38.98 Delayed Data As of May 26 |  -0.24 / -0.61%Today’s Change | 32.44 Today|||52-Week Range 76.45 | +11.72% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | -22.7M | -19.1M | -21.9M | -25.7M | |
| Depreciation | 1.2M | 1.2M | 1.3M | 1.3M | ||
| Total Other Cash Flow | 4.5M | 3.0M | 3.4M | 3.5M | ||
| Funds From Operations | -17.1M | -14.8M | -17.3M | -20.9M | ||
| Funds From/For Other Operating Expenses | -4.6M | -6.3M | 4.2M | 6.8M | ||
| Net Cash Flow - Operating Activities | -12.5M | -8.5M | -21.5M | -27.7M | ||
| Investing | Increase In Investments | 0.00 | -254.6M | -19.3M | -163.3M | |
| Decrease In Investments | 0.00 | 0.00 | 26.5M | 187.5M | ||
| Capital Expenditures | -2.0M | -1.6M | -1.5M | -941.0K | ||
| Fixed Asset Disposal | -- | 131.0K | -- | -- | ||
| Net Cash Flow Investing | -2.0M | -256.0M | 5.7M | 23.2M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 2.2M | 30.2M | 4.0M | 6.5M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 2.2M | 30.2M | 4.0M | 6.5M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -12.3M | -234.4M | -11.8M | 2.0M | ||
